<<

RESEARCH HIGHLIGHTS www.nature.com/clinicalpractice/gasthep

Improved prediction of than previously thought. Many published stud- nontransplant surgical mortality ies have been limited to samples of older indi- in patients with cirrhosis viduals. Bharucha and colleagues recently used the Fecal Incontinence and The Child–Turcotte–Pugh classification system Questionnaire to evaluate the prevalence and is routinely used to calculate the severity of cir- severity of fecal incontinence, and its impact on rhotic , and to determine prognosis quality of life, in a population of women. in medical management of the condition; how- The questionnaire was completed by 2,800 ever, this scheme has limitations, and performs women from Olmsted County (MN, USA); poorly in prediction of postoperative survival in it requested specific information regarding cirrhotic patients. fecal incontinence, but excluded leakage The Model for End-Stage Liver Disease during flatus or diarrheal illness. Women who (MELD) is based on three objective, easily had experienced fecal incontinence during obtained variables (serum International the past 12 months were then asked addi- Normalized Ratio, total bilirubin, and creatinine tional questions regarding its impact on their levels) and is highly predictive of mortality rates quality of life. in many clinical scenarios. The ability of MELD The results indicated an age-adjusted occur- to predict 30-day postoperative mortality rates rence of fecal incontinence of 12.1%, with in patients with cirrhosis was assessed in a prevalence increasing with older age; how- study of 131 patients undergoing a total of 140 ever, severity did not increase with older age. nontransplant surgical procedures. Moderate to severe fecal incontinence was Overall, the 30-day mortality rate was recorded for almost 1 in 15 women. In 23% of 16.4%. The mean MELD score at admission the sampled women, one or more quality-of-life was significantly higher in patients who died domains were reported as being moderately or compared with those who survived beyond severely impacted by fecal incontinence, with the 30 days (23.3 versus 16.9, respectively; impact being related to the severity of symptoms P = 0.0003). Those patients who underwent experienced. With regards to health-seeking intra-abdominal surgery had a higher mortal- behavior, only 10% of the women suffering from ity rate (23.9%), and again the mean MELD fecal incontinence had consulted a physician for score at admission was significantly higher this condition in the previous 12 months. in patients who died compared with those The authors conclude that fecal inconti- who survived (24.8 versus 16.2, respectively; nence is common in this sample population, P = 0.0001). Generally, for patients with MELD and in those with moderate or severe symp- scores <20, there is a 1% increase in mortality toms there is a significant impact on quality of rate for each extra point on the MELD scale; life. In addition, the need for further studies of for those with MELD scores >20, each point the risk factors for and mechanisms of fecal increase on the scale correlates with a 2% incontinence is highlighted. increase in mortality rate. Katy Cherry The authors conclude that the MELD score Original article Bharucha AE et al. (2005) Prevalence and shows promise as a preoperative predictor of burden of fecal incontinence: a population-based study in surgical mortality rate in patients with varying women. 129: 42–49 degrees of cirrhosis. Carol Lovegrove

Original article Northup PG et al. (2005) Model for End- stage Liver Disease (MELD) predicts nontransplant surgical Long-term use of aspirin mortality in patients with cirrhosis. Ann Surg 242: 241–251 and NSAIDs reduces the risk of colorectal cancer

Short-term trials have shown that regular use A population-based study of aspirin reduces the risk of recurrent of fecal incontinence in women colorectal adenoma; however, long-term data on the effects of aspirin or other nonsteroidal Studies have suggested that fecal incontinence anti-inflammatory drugs (NSAIDs) on the risk is more prevalent in the general population of colorectal cancer are limited.

498 NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY NOVEMBER 2005 VOL 2 NO 11

© 2005 Nature Publishing Group